Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EXACT SCIENCES CORP Director's Dealing 2012

Jan 4, 2012

30597_dirs_2012-01-04_1e2aba7d-ddc5-4e57-8449-ee66355f0005.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: EXACT SCIENCES CORP (EXAS)
CIK: 0001124140
Period of Report: 2011-07-05

Reporting Person: Conroy Kevin T (Director, President and CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2011-07-05 Common Stock G 2919 Disposed 43751 Direct
2011-07-13 Common Stock G 2890 Disposed 40861 Direct
2011-12-31 Common Stock M 37767 Acquired 78628 Direct
2011-12-31 Common Stock F 16410 $8.12 Disposed 62218 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-12-31 Restricted Stock Units $ A 113300 Acquired Common Stock (113300) Direct
2011-12-31 Restricted Stock Units $ M 37767 Disposed Common Stock (75533) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11894 Indirect

Footnotes

F1: Includes 4,031 shares acquired under the Exact Sciences Corporation Employee Stock Purchase Plan on May 2, 2011.

F2: Represents shares of common stock received upon vesting of a restricted stock unit award.

F3: Each restricted stock unit represents a contingent right to receive one share of common stock.

F4: Represents a restricted stock unit award granted on February 17, 2011 and earned on December 31, 2011 based on the satisfaction of certain performance-based vesting requirements. The restricted stock units vest in three equal annual installments beginning on December 31, 2011.